2,980
Views
9
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: MEDICAL ONCOLOGY

Maintenance therapy after allogeneic hematopoietic transplant for acute myeloid leukemia: a systematic review and meta-analysis

ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, , & show all
Pages 1335-1341 | Received 29 Apr 2021, Accepted 10 Jul 2021, Published online: 30 Jul 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Lalit Saini, James D Griffin, Bhavik J Pandya, Manasee V Shah, Mo Zhou, Hongbo Yang, Yan Song & Deborah A Marshall. (2023) Patient and Physician Preferences for Acute Myeloid Leukemia Maintenance Treatments Following Hematopoietic Stem Cell Transplantation. Patient Preference and Adherence 17, pages 2805-2819.
Read now
Xiaoli Zhao, Mengze Hao, Xiaoyu Zhang, Jialin Wei, Sizhou Feng, Yi He, Erlie Jiang & Mingzhe Han. (2023) Post-HSCT Maintenance Treatment Using Entrectinib for an AML Patient Accompanied with ETV6::NTRK3: A Case Report. OncoTargets and Therapy 16, pages 1055-1059.
Read now
Li Li, Ran Zhang, Weijie Cao, Zhilei Bian, Yang Qin, Rong Guo, Suping Zhang, Yingnan Peng, Dingming Wan & Wang Ma. (2023) Comparative analysis of hypomethylating agents as maintenance therapy after allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia. Leukemia & Lymphoma 64:13, pages 2113-2122.
Read now

Articles from other publishers (6)

Andrea C. Betts, Caitlin C. Murphy, L. Aubree Shay, Bijal A. Balasubramanian, Christine Markham, Michael E. Roth & Marlyn Allicock. (2022) Polypharmacy and medication fill nonadherence in a population-based sample of adolescent and young adult cancer survivors, 2008–2017. Journal of Cancer Survivorship 17:6, pages 1688-1697.
Crossref
Yuho Najima. (2023) Overcoming relapse: prophylactic or pre-emptive use of azacitidine or FLT3 inhibitors after allogeneic transplantation for AML or MDS. International Journal of Hematology 118:2, pages 169-182.
Crossref
Uri Ilan, Erica Brivio, Mattia Algeri, Adriana Balduzzi, Marta Gonzalez-Vincent, Franco Locatelli, Christian Michel Zwaan, Andre Baruchel, Caroline Lindemans & Francisco Bautista. (2023) The Development of New Agents for Post-Hematopoietic Stem Cell Transplantation Non-Infectious Complications in Children. Journal of Clinical Medicine 12:6, pages 2149.
Crossref
Shai Shimony, Maximilian Stahl & Richard M. Stone. (2023) Acute myeloid leukemia: 2023 update on diagnosis, risk‐stratification, and management. American Journal of Hematology 98:3, pages 502-526.
Crossref
A. Sherban, P. Raanani, R. Gurion, O. Wolach & A. Gafter-Gvili. (2022) Maintenance therapy with hypomethylating agents for patients with acute myeloid leukemia in first remission not eligible for allogeneic hematopoietic cell transplantation: A systematic review and meta-analysis. Leukemia Research 113, pages 106773.
Crossref
Zhihua Wu, Pei Zhu, Hao Yan, Tiansheng Zeng & Lin Fu. (2022) Hypomethylating Agents as Maintenance Therapy in the Treatment of Elderly Acute Myeloid Leukemia:A Meta-Analysis. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.